Here's Why BioNTech Stock Is Moving

BioNTech SE - ADR BNTX shares are trading higher in sympathy with Moderna Inc MRNA, which reported better-than-expected second-quarter results.

Quarterly revenue for Moderna was $4.75 billion compared to $4.34 million a year ago, beating the consensus of $4.07 billion.

Moderna has authorized an additional share repurchase program for $3 billion. The $3 billion repurchase program announced in February is continuing and currently has approximately $1 billion outstanding... Read More

See Also: Why Kintara Therapeutics Stock Is Skyrocketing Today

According to data from Benzinga Pro, BioNTech has a 52-week high of $464.00 and a 52-week low of $117.08.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: MoversTrading Ideaswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!